| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/02/2000 | CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 08/02/2000 | CN1261797A Self-emulsifying formulation forlipophilic compounds |
| 08/02/2000 | CN1261796A Self-emulsifying formulation for lipophilic compounds |
| 08/02/2000 | CN1261790A Self-emulsifying formulation for lipophilic compounds |
| 08/01/2000 | US6096897 Endothelin receptor antagonists |
| 08/01/2000 | US6096895 Heterocyclic dihydrazole compounds and their use for controlling fungal plant diseases |
| 08/01/2000 | US6096840 Gas phase polymerization process |
| 08/01/2000 | US6096794 Photoinitiator system for photopolymerization of ethylenically unsaturated polymerizable compounds |
| 08/01/2000 | US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding |
| 08/01/2000 | US6096754 N-3 substituted pyrimidin-4-ones with AII antagonistic activity |
| 08/01/2000 | US6096753 Substituted pyrimidinone and pyridone compounds and methods of use |
| 08/01/2000 | US6096752 Method for the preparation of tertiary amines, a compound useful therefor and alpha-2-receptor active tetrahydroisoquinoline derivatives |
| 08/01/2000 | US6096745 Imidazolone anorectic agents: III. heteroaryl derivatives |
| 08/01/2000 | US6096740 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions |
| 08/01/2000 | US6096739 Treatment for CNS injuries |
| 08/01/2000 | US6096735 Benzoheterocyclic derivatives |
| 08/01/2000 | US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors |
| 08/01/2000 | US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents |
| 08/01/2000 | US6096689 5-pyrazolylbenzoic acid derivatives as herbicides |
| 08/01/2000 | CA2178760C Hiv protease inhibitors |
| 07/30/2000 | CA2297225A1 O-substituted hydroxycoumaranone derivatives as antitumor and antimetastatic agents |
| 07/27/2000 | WO2000043390A1 Antifungal azole derivatives having a fluorinated vinyl group and process for preparing same |
| 07/27/2000 | WO2000043389A1 Novel cationic di-methylenedioxy-benzenes, their use for oxidation dyeing of keratin fibres |
| 07/27/2000 | WO2000043388A1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods |
| 07/27/2000 | WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents |
| 07/27/2000 | WO2000043383A1 Piperidinylquinolines as protein tyrosine kinase inhibitors |
| 07/27/2000 | WO2000043382A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use |
| 07/27/2000 | WO2000043373A2 Kinase inhibitors |
| 07/27/2000 | WO2000043372A1 Acyl derivatives which treat vla-4 related disorders |
| 07/27/2000 | WO2000043369A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043356A1 Novel cationic couplers and their use for oxidation dyeing |
| 07/27/2000 | WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | WO2000043010A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 07/27/2000 | WO2000043009A1 Pyridine compounds, use and preparation thereof |
| 07/27/2000 | WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation |
| 07/27/2000 | WO2000020399A3 Use of substituted 5-hydroxypyrazoles, novel 5-hydroxypyrazoles, methods for the production thereof and agents containing the same |
| 07/27/2000 | WO2000018358A3 Method of treating hair loss using ketoamides |
| 07/27/2000 | WO2000008202A9 3-methylidenyl-2-indolinone modulators of protein kinase |
| 07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
| 07/27/2000 | WO1999062881A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 07/27/2000 | CA2361059A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use |
| 07/27/2000 | CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | CA2359680A1 Kinase inhibitors |
| 07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2323708A1 Novel cationic couplers and their use for oxidation dyeing |
| 07/27/2000 | CA2322996A1 Novel cationic di-methylenedioxy-benzenes, their use for oxidation dyeing of keratin fibres |
| 07/27/2000 | CA2322990A1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods |
| 07/26/2000 | EP1022277A1 New taxane derivatives |
| 07/26/2000 | EP1022276A1 Epoxysuccinamide derivatives |
| 07/26/2000 | EP1021457A1 Method for the site specific synthesis of novel 3-hydroxypyridin-4(1h)-ons derivatives from aminomonosaccharides or aminoitols, products obtained by this method and their applications |
| 07/26/2000 | EP1021441A1 Substituted 2,4-diamino-1,3,5-triazine and their use as herbicides |
| 07/26/2000 | EP1021439A1 Crystalline antifungal polymorph |
| 07/26/2000 | EP1021437A1 Arylsulfonylimidazolone derivatives as an antitumor agent |
| 07/26/2000 | EP1021432A1 Halogen substituted tetracyclic tetrahydrofuran derivatives |
| 07/26/2000 | EP1021429A1 Aryl furan derivatives as pde iv inhibitors |
| 07/26/2000 | EP1021414A1 Frangible compounds for pathogen inactivation |
| 07/26/2000 | EP1021411A1 Benzamide derivatives as thrombin inhibitors |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/26/2000 | EP1021405A1 Azetidinone derivatives for the treatment of hcmv infections |
| 07/26/2000 | EP1021185A1 Didhydropyrimidines and uses thereof |
| 07/26/2000 | EP1021181A1 Carboxylic acid indole inhibitors of chemokines |
| 07/26/2000 | EP0755253B1 Intranasal antimigraine composition |
| 07/26/2000 | CN1261354A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261353A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261350A Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors |
| 07/26/2000 | CN1261348A Dihydropyridine derivatives |
| 07/26/2000 | CN1261072A 7-halogenated and 7 beta, 8 beta-methylene-taxinol, its usage against cancers and medicinal compositions containing it |
| 07/26/2000 | CN1054854C Insecticidal tetrahydrofuran-compound |
| 07/26/2000 | CN1054853C Prepn. of 1-[2-(2,4-difluorophenyl) 2,3-epoxypropyl]-1H-1,2,4-triazole as intermediate of fluconazole and its methyl sulphonate |
| 07/26/2000 | CN1054851C 3-aryl-pyrone derivatives and their preparing methods and uses as pesticides and herbicides |
| 07/26/2000 | CN1054844C N-substituted azabicycloheptane derivatives, their preparation and use |
| 07/26/2000 | CN1054842C 1-amidinophenyl-pyrrolidones piperidinones azetinones platelet aggregation inhibitors |
| 07/25/2000 | US6093812 Process for the stereospecific synthesis of azetidinones |
| 07/25/2000 | US6093732 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 07/25/2000 | US6093731 Isoquinolines |
| 07/25/2000 | US6093725 Frangible compounds for pathogen inactivation |
| 07/25/2000 | US6093714 An antiallergens for treatment and prevention of bronchial asthma, eczema, hives, allergic gastrointestinal troubles, allergic rhinitis, allergic conjunctivitis |
| 07/25/2000 | CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 07/25/2000 | CA2169115C 1-¬2-(substituted vinyl)|-5h-2,3-benzodiazepine derivatives |
| 07/20/2000 | WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 07/20/2000 | WO2000042026A1 Non-peptide glp-1 agonists |
| 07/20/2000 | WO2000042019A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000014097A3 Novel pyranoses |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/20/2000 | WO1999000373A8 Benzimidazole derivatives |
| 07/20/2000 | CA2359952A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | CA2359942A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | CA2359416A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/19/2000 | EP1020464A1 Paroxetine methansulfonate |
| 07/19/2000 | EP1020463A1 Paroxetine methanesulfonate |
| 07/19/2000 | EP1020453A1 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid deri vatives, addition salts thereof, and processes for the preparation of both |
| 07/19/2000 | EP1020452A1 Benzimidazole derivatives |
| 07/19/2000 | EP1020445A1 Fused pyridine derivatives |
| 07/19/2000 | EP1019530A1 A method of treating cancer |
| 07/19/2000 | EP1019399A1 Aryl thiophene derivatives as pde iv inhibitors |
| 07/19/2000 | EP1019398A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 07/19/2000 | EP1019397A1 A process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives |